Mary Shoemaker
Directeur/Bestuurslid bij TRAWS PHARMA, INC.
Vermogen: 2 141 $ op 30-04-2024
Actieve functies van Mary Shoemaker
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TRAWS PHARMA, INC. | Directeur/Bestuurslid | 01-04-2020 | - |
Independent Dir/Board Member | 01-04-2020 | - |
Loopbaan van Mary Shoemaker
Eerdere bekende functies van Mary Shoemaker
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MEDEXUS PHARMACEUTICALS INC. | Corporate Officer/Principal | - | 22-05-2020 |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Directeur/Bestuurslid | 01-10-2018 | 01-05-2020 |
Algemeen Directeur | 01-01-2012 | 01-05-2020 | |
President | 01-10-2018 | 01-05-2020 | |
INTERMUNE INC | Verkoop & Marketing | 06-11-2009 | 01-07-2010 |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - | - |
Opleiding van Mary Shoemaker
Missouri State University | Undergraduate Degree |
University of Central Missouri | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Canada | 2 |
Operationeel
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sales & Marketing | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MEDEXUS PHARMACEUTICALS INC. | Health Technology |
TRAWS PHARMA, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
- Beurs
- Insiders
- Mary Shoemaker
- Ervaring